Renal Cell Carcinoma is More Aggressive in Turkish Patients with the Metabolic Syndrome

Ozbek, Emin; Otunctemur, Alper; Sahin, Suleyman; Dursun, Murat; Besiroglu, Huseyin; Koklu, Ismail; Polat, Emre Can; Erkoc, Mustafa; Danis, Eyyup; Bozkurt, Muammer

추천

검색

자료유형: 학술저널

저자정보: Ozbek, Emin (Department of Urology, Okmeydani Training and Research Hospital) Otunctemur, Alper (Department of Urology, Okmeydani Training and Research Hospital) Sahin, Suleyman (Department of Urology, Okmeydani Training and Research Hospital) Dursun, Murat (Department of Urology, Okmeydani Training and Research Hospital) Besiroglu, Huseyin (Department of Urology, Okmeydani Training and Research Hospital) Koklu, Ismail (Department of Urology, Okmeydani Training and Research Hospital) Polat, Emre Can (Department of Urology, Balikligol State Hospital) Erkoc, Mustafa (Department of Urology, Okmeydani Training and Research Hospital) Danis, Eyyup (Department of Urology, Okmeydani Training and Research Hospital) Bozkurt, Muammer (Department of Urology, Okmeydani Training and Research Hospital)

저널정보: 아시아태평양암예방학회 Asian Pacific journal of cancer prevention : APJCP Asian Pacific journal of cancer prevention : APJCP 제14권 제12호

발행연도: 2013.1

수록면: 7,351 - 7,354 (4page)

이용수

📌

연구주제

📖

연구배경

🔬

연구방법

🏆

연구결과

초록· 키워드

오류제보하기

Background: Metabolic syndrome (MetS) is a multifactorial disease characterized by impaired glucose tolerance/diabetes, obesity, high triglyceride levels, low HDL levels, and hypertension. In this study we evaluate the relationship between tumor size and grade, and presence of the metabolic syndrome in patients with renal cell carcinoma. Materials and Methods: Between 2007-2013, radical nephrectomy was performed for 310 patients with renal tumors in our clinic and those with pathology reported renal cell carcinoma were enrolled and divided into two groups, with and without metabolic syndrome diagnosed on the basis of the National Cholesterol Education Program (NCEP) Adult Treatment Panel III (ATP III) criteria. The relationship between tumor size and grade of the two groups (Fuhrman nuclear degree) was evaluated statistically. Results: The metabolic syndrome was found in 70 patients, with a mean age of 65.5 (40-87), as compared to 58.8 (31-84) years in the non-metabolic syndrome group. Tumor size over 7 cm was found in 54% and 33%, respectively, and tumor grade over Fuhrman 3 in 56% and 32% of patients. Patients with metabolic syndrome had significantly higher tumor size and grade (p<0.05). In the presence of hypertension, diabetes and high triglyceride levels, significant assocations were again observed (p<0.05). Tumor size and degree also increased with increasing body mass index but this was not statistically significant (p>0.05). Conclusions: Renal cancer is more aggressive in patients with metabolic syndrome. Lifestyle and risk factors were revealed to be significant influences in renal cancer patients.

#Metabolic syndrome #renal cell carcinoma #tumor size #Furhman grade

참고문헌 (0)

참고문헌 신청

참고문헌이 DBpia에서 서비스 중이라면, [참고문헌 신청]을 통해 등록해보세요